Treatment drugs for malignant mesothelioma

JP7870053B2Active Publication Date: 2026-06-04AICHI MEDICAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2021169563
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-10-15
Publication Date
2026-06-04
Estimated Expiration
2041-10-15
Patent Text Reader

Abstract

To provide an agent for treating malignant mesothelioma that can kill specifically cancer cells and has few adverse effects.SOLUTION: An agent for treating malignant mesothelioma contains cerulenin and / or a derivative thereof or KN-93 and / or a derivative thereof as an active ingredient.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art